SMTL ID : 5bms.1

Crystal structure of P21-activated kinase 4 in complex with an inhibitor compound 29

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

monomer

Ligands

1 x 4T6: N~2~-[(7-chloro-1H-benzimidazol-6-yl)methyl]-N~4~-(5-cyclopropyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine(Non-covalent)

4T6.1: 13 residues within 4Å: Chain A: I.29, G.30, E.31, V.37, A.50, M.97, E.98, F.99, L.100, G.103, D.146, L.149, D.160 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.37, A:A.50, A:L.149, A:L.149 Hydrogen bonds: A:E.98, A:L.100, A:L.100

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Crawford, J.J. et al., Structure-Guided Design of Group I Selective p21-Activated Kinase Inhibitors. J.Med.Chem. (2015)

Release Date

2015-07-01

Peptides

Serine/threonine-protein kinase PAK 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase PAK 4

Related Entries With Identical Sequence